Sequoia Financial Advisors LLC Raises Holdings in DaVita Inc. (NYSE:DVA)

Sequoia Financial Advisors LLC boosted its stake in shares of DaVita Inc. (NYSE:DVA) by 6.2% in the 4th quarter, HoldingsChannel reports. The fund owned 1,897 shares of the company’s stock after buying an additional 110 shares during the quarter. Sequoia Financial Advisors LLC’s holdings in DaVita were worth $284,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. SoundView Advisors Inc. bought a new position in shares of DaVita in the 4th quarter worth approximately $595,000. Moran Wealth Management LLC boosted its stake in shares of DaVita by 102.2% in the 4th quarter. Moran Wealth Management LLC now owns 110,322 shares of the company’s stock worth $16,499,000 after buying an additional 55,756 shares during the last quarter. Amundi boosted its stake in shares of DaVita by 116.4% in the 4th quarter. Amundi now owns 446,386 shares of the company’s stock worth $68,726,000 after buying an additional 240,126 shares during the last quarter. PNC Financial Services Group Inc. boosted its stake in shares of DaVita by 0.9% in the 4th quarter. PNC Financial Services Group Inc. now owns 12,854 shares of the company’s stock worth $1,922,000 after buying an additional 118 shares during the last quarter. Finally, E Fund Management Co. Ltd. purchased a new position in DaVita during the fourth quarter valued at $328,000. Hedge funds and other institutional investors own 90.12% of the company’s stock.

DaVita Trading Up 0.4 %

Shares of DaVita stock opened at $150.00 on Thursday. The stock has a market cap of $12.00 billion, a P/E ratio of 13.97, a P/E/G ratio of 1.07 and a beta of 0.99. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.26 and a quick ratio of 1.21. The stock’s 50 day simple moving average is $158.73 and its 200-day simple moving average is $157.55. DaVita Inc. has a 1-year low of $125.64 and a 1-year high of $179.60.

DaVita (NYSE:DVA) last issued its earnings results on Thursday, February 13th. The company reported $2.24 EPS for the quarter, topping analysts’ consensus estimates of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. Analysts predict that DaVita Inc. will post 10.76 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on DVA shares. Sanford C. Bernstein set a $184.00 price objective on DaVita in a research report on Friday, February 21st. Barclays boosted their price objective on DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 18th. Finally, Cowen restated a “hold” rating on shares of DaVita in a research report on Tuesday, February 18th. One analyst has rated the stock with a sell rating, four have given a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, DaVita has a consensus rating of “Hold” and a consensus target price of $166.33.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.